Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa

Blackwell Publishing
Publication Type:
Journal Article
Journal of Neurochemistry, 2006, 98 (4), pp. 1061 - 1067
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010000597OK.pdf192.91 kB
Adobe PDF
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's disease. There is concern that chronic L-dopa treatment may be detrimental, with some studies suggesting that L-dopa may be neurotoxic. A potentially important mech
Please use this identifier to cite or link to this item: